Frag' FlorenceEvidenz. Klar. Anwendbar.
Uhr 7/8Sources Journal Tree
Easy Demo

Lokaler Crossref-Datenbestand · journal-article

Potential drug–drug interactions and clinical outcomes among people living with HIV with comorbidities: A multicentre retrospective cohort study

Chanadda Wuttikul, Noppaket Singkham, Chadathorn Hongsudta, Jindarat Danpan, Chontawan Wannagon, Wuttikrai Chaimipak, Prakaikaew Jaiwanglok, Puttasorn Detmon, Sirayut Phattanasobhon

British Journal of Clinical Pharmacology · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Aims This study aimed to determine the prevalence and patterns of potential drug–drug interactions (pDDIs), identify associated factors among people living with HIV (PLWH) with comorbidities and examine associations with clinical outcomes. Methods This multicentre retrospective study was conducted across three healthcare tiers in Thailand during 2023–2024. pDDIs were identified using Lexicomp (categories A–X). Multivariable logistic regression identified factors associated with pDDIs and assessed associations with viral suppression (viral load

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Chanadda Wuttikul, Noppaket Singkham, Chadathorn Hongsudta, Jindarat Danpan, Chontawan Wannagon, Wuttikrai Chaimipak, Prakaikaew Jaiwanglok, Puttasorn Detmon, Sirayut Phattanasobhon
Quelle
British Journal of Clinical Pharmacology
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
0306-5251, 1365-2125
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Chanadda Wuttikul, Noppaket Singkham, Chadathorn Hongsudta, Jindarat Danpan, Chontawan Wannagon, Wuttikrai Chaimipak, Prakaikaew Jaiwanglok, Puttasorn Detmon, Sirayut Phattanasobhon (2026). Potential drug–drug interactions and clinical outcomes among people living with HIV with comorbidities: A multicentre retrospective cohort study. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70794
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1 · Lizenz 2